Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis
- PMID: 3062134
- DOI: 10.1007/BF00314245
Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis
Abstract
Azathioprine (Aza) has been used alone or in combination with steroids for two groups of myasthenic patients. Positive responses were noted in 75% of patients on Aza alone and in 70% receiving the combined regimen. The clinical course of the two groups differed in terms of respiratory crisis and need for plasma exchange. With an appropriate Aza administration schedule side-effects were not a limiting factor to its use. Aza treatment induced a reduction in anti-AchR-antibody level that was correlated with clinical improvement and greatly decreased the need for steroids.
Similar articles
-
A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group.Neurology. 1998 Jun;50(6):1778-83. doi: 10.1212/wnl.50.6.1778. Neurology. 1998. PMID: 9633727 Clinical Trial.
-
Azathioprine as a single immunosuppressive drug in the treatment of myasthenia gravis.Acta Neurol (Napoli). 1993 Apr;15(2):123-31. Acta Neurol (Napoli). 1993. PMID: 8328322
-
Azathioprine in the treatment of myasthenia gravis.Ann Neurol. 1984 Jun;15(6):602-5. doi: 10.1002/ana.410150615. Ann Neurol. 1984. PMID: 6742794
-
Cancer occurrence following azathioprine treatment in myasthenia gravis patients: A systematic review and meta-analysis.J Clin Neurosci. 2021 Jun;88:70-74. doi: 10.1016/j.jocn.2021.03.015. Epub 2021 Apr 2. J Clin Neurosci. 2021. PMID: 33992207
-
Steroids and immunosuppressant drugs in myasthenia gravis.Nat Clin Pract Neurol. 2008 Jun;4(6):317-27. doi: 10.1038/ncpneuro0810. Epub 2008 May 20. Nat Clin Pract Neurol. 2008. PMID: 18493241 Review.
Cited by
-
Guideline for the management of myasthenic syndromes.Ther Adv Neurol Disord. 2023 Dec 26;16:17562864231213240. doi: 10.1177/17562864231213240. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 38152089 Free PMC article. Review.
-
Acute treatment of myasthenia gravis with intranasal neostigmine: clinical and electromyographic evaluation.J Neurol Neurosurg Psychiatry. 1991 Dec;54(12):1061-2. doi: 10.1136/jnnp.54.12.1061. J Neurol Neurosurg Psychiatry. 1991. PMID: 1783916 Free PMC article.
-
The MG Composite: A valid and reliable outcome measure for myasthenia gravis.Neurology. 2010 May 4;74(18):1434-40. doi: 10.1212/WNL.0b013e3181dc1b1e. Neurology. 2010. PMID: 20439845 Free PMC article.
-
Changes in peripheral blood lymphocyte subset frequencies in myasthenia gravis patients are related to immunosuppression.J Neurol. 1994 Feb;241(4):218-22. doi: 10.1007/BF00863771. J Neurol. 1994. PMID: 8195820
-
The relationship between health, disability and quality of life in myasthenia gravis: results from an Italian study.J Neurol. 2010 Jan;257(1):98-102. doi: 10.1007/s00415-009-5279-z. Epub 2009 Aug 8. J Neurol. 2010. PMID: 19669388